These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 17925591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand.
    Wang B, Nichol JL, Sullivan JT.
    Clin Pharmacol Ther; 2004 Dec; 76(6):628-38. PubMed ID: 15592334
    [Abstract] [Full Text] [Related]

  • 3. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.
    Newland A, Caulier MT, Kappers-Klunne M, Schipperus MR, Lefrere F, Zwaginga JJ, Christal J, Chen CF, Nichol JL.
    Br J Haematol; 2006 Nov; 135(4):547-53. PubMed ID: 17061981
    [Abstract] [Full Text] [Related]

  • 4. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
    Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL.
    N Engl J Med; 2006 Oct 19; 355(16):1672-81. PubMed ID: 17050891
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug evaluation: AMG-531 for the treatment of thrombocytopenias.
    Rice L.
    Curr Opin Investig Drugs; 2006 Sep 19; 7(9):834-41. PubMed ID: 17002262
    [Abstract] [Full Text] [Related]

  • 7. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
    Kuter DJ.
    Eur J Haematol Suppl; 2008 Feb 19; (69):9-18. PubMed ID: 18211568
    [Abstract] [Full Text] [Related]

  • 8. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A, Sesoko S, Nakashima M, Hayashi N, Taniguchi A, Horie Y, Graefe-Mody EU, Woerle HJ, Dugi KA.
    Clin Ther; 2010 Jun 19; 32(6):1188-204. PubMed ID: 20637971
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.
    Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM.
    J Bone Miner Res; 2004 Jul 19; 19(7):1059-66. PubMed ID: 15176987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
    van Der Auwera P, Platzer E, Xu ZX, Schulz R, Feugeas O, Capdeville R, Edwards DJ.
    Am J Hematol; 2001 Apr 19; 66(4):245-51. PubMed ID: 11279634
    [Abstract] [Full Text] [Related]

  • 14. Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.
    Trinchard-Lugan I, Ho-Nguyen Q, Bilham WM, Buraglio M, Ythier A, Munafo A.
    Eur Cytokine Netw; 2001 Apr 19; 12(3):391-8. PubMed ID: 11566619
    [Abstract] [Full Text] [Related]

  • 15. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A.
    Semin Hematol; 2007 Oct 19; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [Abstract] [Full Text] [Related]

  • 16. [Clinical tolerance test of recombinant human thrombopoietin].
    Zhao Y, Jiang J, Jiao L.
    Zhonghua Yi Xue Za Zhi; 2001 Dec 25; 81(24):1508-11. PubMed ID: 16200777
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
    Herbst RS, Hong D, Chap L, Kurzrock R, Jackson E, Silverman JM, Rasmussen E, Sun YN, Zhong D, Hwang YC, Evelhoch JL, Oliner JD, Le N, Rosen LS.
    J Clin Oncol; 2009 Jul 20; 27(21):3557-65. PubMed ID: 19546406
    [Abstract] [Full Text] [Related]

  • 19. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
    McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore D, Blackman N, Jenkins J, Afdhal NH, TPL102357 Study Group.
    N Engl J Med; 2007 Nov 29; 357(22):2227-36. PubMed ID: 18046027
    [Abstract] [Full Text] [Related]

  • 20. Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.
    Karlan BY, Oza AM, Richardson GE, Provencher DM, Hansen VL, Buck M, Chambers SK, Ghatage P, Pippitt CH, Brown JV, Covens A, Nagarkar RV, Davy M, Leath CA, Nguyen H, Stepan DE, Weinreich DM, Tassoudji M, Sun YN, Vergote IB.
    J Clin Oncol; 2012 Feb 01; 30(4):362-71. PubMed ID: 22184370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.